provides a comprehensive understanding of the current literature on genomics and exposomic technologies relating to Parkinson's Disease etiology. This emerging field uses large omics datasets to investigate the etiology of Parkinson’s disease and other forms of parkinsonisms. The book begins by introducing the readers to evolution of omics technologies, starting with the first identification of monogenic forms of Parkinson’s disease. Next, a series of chapters covering genomics, transcriptomics, and epigenomics, including artificial intelligence and gene-environment interaction are included. Lastly, potential application of advances in the field to therapy and what is in store for the future generation for omics in Parkinson's Disease are reviewed.